One Drop Named to the New York Digital Health 100

One Drop Named to the New York Digital Health 100
Precision health company appears on exclusive list recognizing the most exciting and innovative health startups in the New York region

NEW YORK, February 1, 2023One Drop, a leader in precision health solutions for people living with chronic conditions worldwide, today announced that it has been named to the New York Digital Health 100 (DH100), a recognition that highlights the most exciting and innovative startups in the New York region, for the second consecutive year. Digital Health New York (DHNY) publishes the annual list as part of the New York Healthcare Innovation Report—a comprehensive analysis that looks at the data, trends, and people that have propelled New York to become the capital of healthcare innovation. 

“We are honored to appear on the New York Digital Health 100 for the second year in a row,” said Jeff Dachis, CEO and founder of One Drop. “At One Drop, our North Star has always been meeting the needs of people living with diabetes and other chronic conditions. As a global financial and cultural hub, New York City continues to offer our organization unmatched access to cultural and capital resources as well as diversity and quality of talent needed to develop a minimally invasive health sensor while maintaining the award-winning digital platform our existing members rely on every day.”

After receiving a type 1 diabetes diagnosis at age 46, CEO Jeff Dachis recognized the shortcomings of traditional healthcare and identified a massive market opportunity to digitally transform diabetes care. Today, One Drop members in all 195 countries use the AI-enabled digital health platform to proactively manage their health with continuous, personalized support from predictive insights—powered by more than 45 billion data points, clinical health coaching, and connected medical devices, including an award-winning smart glucose meter.

One Drop is currently developing a minimally invasive health sensor with continuous glucose monitoring (CGM) capabilities designed to provide greater flexibility and insights for people with diabetes compared to blood glucose monitoring (BGM) fingersticks alone. Pending regulatory approval and commercial adoption, One Drop believes that integrating its proprietary sensor and existing digital solution should augment proven outcomes and yearly cost savings for members with diabetes and other chronic conditions. The availability of this device is subject to receipt of clearance or approval from the U.S. Food and Drug Administration.

“In 2023, the New York Digital Health 100 includes an incredibly diverse, innovative, and forward-thinking set of companies and leaders that are making an impact on the future of healthcare,” said Bunny Ellerin, co-founder and CEO of DHNY. “On behalf of the entire New York healthcare ecosystem, we are delighted to spotlight these organizations, support their growth and applaud them for their meaningful contributions to improving healthcare.”

Now in its fourth year, the DH100 received double the number of applicants compared to 2022. With this explosive growth, the scope of the list greatly expanded, and now represents 35 new companies; counts 12 unicorns among its ranks; has 23 organizations led by female CEOs; and 37 of the companies on the list raised $1.6B in 2022.

Download a copy of the New York Healthcare Innovation Report here.


About Digital Health New York (DHNY)

Digital Health New York (DHNY) is the premier network of CEOs, entrepreneurs, investors, payers and providers driving New York’s healthcare ecosystem. DHNY works to increase the visibility of New York as a leader in healthcare innovation, showcases the organizations and leaders curating the future of healthcare, and brings people together to share ideas, spark new directions and create success. For more information, visit